NAD-HD
The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease
Phase 2 study testing a dietary supplement to see whether it can slow the progression of Huntington's disease.
RecruitingPhase 2Dietary SupplementClinicalTrials.govTreatment trial
Recruiting in: Oslo, Norway
Sponsor: Oslo University Hospital
Preparing a short plain-English summary.